McKesson to retain top wholesaler position following FTC decision on mergers.
This article was originally published in The Tan Sheet
Executive Summary
MCKESSON WOULD RETAIN NUMBER ONE WHOLESALER POSITION following the Federal Trade Commission's March 3 vote to oppose the two pending wholesaler mergers. The leading U.S. drug wholesaler successfully forced a tandem review of its merger with AmeriSource and the proposed merger of Cardinal Health and Bergen Brunswig. McKesson announced its agreement with AmeriSource shortly after the Cardinal/Bergen deal was unveiled.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning